These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1270151)

  • 1. Fusobacterium necrophorum infection in mice as a model for the study of liver abscess formation and induction of immunity.
    Abe PM; Lennard ES; Holland JW
    Infect Immun; 1976 May; 13(5):1473-8. PubMed ID: 1270151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a new murine model of liver abscess induced by Fusobacterium necrophorum injected into the caudal vein.
    Nagaoka K; Yanagihara K; Harada Y; Yamada K; Migiyama Y; Morinaga Y; Izumikawa K; Kakeya H; Nakashima M; Nishimura M; Kohno S
    J Med Microbiol; 2013 Nov; 62(Pt 11):1755-1759. PubMed ID: 23973984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Fusobacterium necrophorum leukotoxoid vaccine on susceptibility to experimentally induced liver abscesses in cattle.
    Saginala S; Nagaraja TG; Lechtenberg KF; Chengappa MM; Kemp KE; Hine PM
    J Anim Sci; 1997 Apr; 75(4):1160-6. PubMed ID: 9110232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of experimentally induced Fusobacterium necrophorum infections in mice.
    Conlon PJ; Hepper KP; Teresa GW
    Infect Immun; 1977 Feb; 15(2):510-7. PubMed ID: 403138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on bacterial synergism in mice infected with Bacteroides intermedius and Fusobacterium necrophorum.
    Price SB; McCallum RE
    J Basic Microbiol; 1987; 27(7):377-86. PubMed ID: 3449614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperbaric oxygen exposures for intrahepatic abscesses produced in mice by nonsporeforming anaerobic bacteria.
    Hill GB
    Antimicrob Agents Chemother; 1976 Feb; 9(2):312-7. PubMed ID: 1267430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo antianaerobe activity of DS-8587, a new fluoroquinolone, against Fusobacterium necrophorum in a mouse model.
    Nagaoka K; Yanagihara K; Morinaga Y; Kurosaka Y; Hoshino K; Kohno S
    J Infect Chemother; 2017 Mar; 23(3):131-135. PubMed ID: 28109739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxin-triggered haematological interactions in Fusobacterium necrophorum infections.
    Garcia GG; Goto Y; Shinjo T
    Microbios; 2000; 102(401):39-44. PubMed ID: 10817519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of vaccination against Fusobacterium necrophorum infection for control of liver abscesses and footrot in feedlot cattle in western Canada.
    Checkley SL; Janzen ED; Campbell JR; McKinnon JJ
    Can Vet J; 2005 Nov; 46(11):1002-7. PubMed ID: 16363327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative biological features of a rat liver abscess model induced with three Fusobacterium necrophorum strains.
    Scanlan CM; Berg JN; Lairmore MD
    Am J Vet Res; 1983 Sep; 44(9):1789-92. PubMed ID: 6625335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serum neutralizing antibody response in cattle to Fusobacterium necrophorum leukotoxoid and possible protection against experimentally induced hepatic abscesses.
    Saginala S; Nagaraja TG; Tan ZL; Lechtenberg KF; Chengappa MM; Hine PM
    Vet Res Commun; 1996; 20(6):493-504. PubMed ID: 8950830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The weak immunogenicity of Fusobacterium necrophorum.
    Smith GR; Turner A; Murray LG; Oliphant JC
    J Hyg (Lond); 1985 Aug; 95(1):59-68. PubMed ID: 3894509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of haemolytic activity between Fusobacterium necrophorum subsp. necrophorum and Fusobacterium necrophorum subsp. funduliforme in vitro and in vivo.
    Shinjo T; Misawa N; Goto Y
    APMIS; 1996 Jan; 104(1):75-8. PubMed ID: 8645462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of mice against Fusobacterium necrophorum infection by perenteral or oral administration of vaccine.
    Abe PM; Holland JW; Stauffer LR
    Am J Vet Res; 1978 Jan; 39(1):115-8. PubMed ID: 629432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and protective effects of truncated recombinant leukotoxin proteins of Fusobacterium necrophorum in mice.
    Narayanan SK; Chengappa MM; Stewart GC; Nagaraja TG
    Vet Microbiol; 2003 Jun; 93(4):335-47. PubMed ID: 12713895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neutralizing antibodies against Fusobacterium necrophorum leukotoxin in cattle with experimentally induced or naturally developed hepatic abscesses.
    Tan ZL; Lechtenberg KF; Nagaraja TG; Chengappa MM; Brandt RT
    J Anim Sci; 1994 Feb; 72(2):502-8. PubMed ID: 8157537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusobacterium necrophorum Endocarditis with Liver Abscesses: A Case Report and Review of the Literature.
    Sato K; Matsubara T; Imai S; Hatada K; Mitsuma W; Kawasaki S; Hama I; Kamura T
    Intern Med; 2021 Aug; 60(15):2445-2449. PubMed ID: 33642481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusobacterium necrophorum hemolysin in bovine hepatic abscess.
    Kanoe M
    Zentralbl Veterinarmed B; 1990 Dec; 37(10):770-3. PubMed ID: 2082629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver abscesses due to Fusobacterium spp that mimick malignant metastatic liver disease.
    Athavale NV; Leitch DG; Cowling P
    Eur J Clin Microbiol Infect Dis; 2002 Dec; 21(12):884-6. PubMed ID: 12525925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological changes produced by Fusobacterium necrophorum in experimental infection of mice.
    Abe PM; Majeski JA; Lennard ES
    J Comp Pathol; 1976 Jul; 86(3):365-9. PubMed ID: 939825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.